Maintenance of clinical efficacy after dose reduction of ixabepilone plus capecitabine in patients with anthracycline- and taxane-resistant metastatic breast cancer: A retrospective analysis of pooled data from 2 phase III randomized clinical trials

Vicente Valero, Eduard Vrdoljak, Binghe Xu, Eva Thomas, Henry Gómez, Alexey Manikhas, Carlos Medina, Rubi Khaw Li, Jungsil Ro, Linda Bosserman, Linda Vahdat, Pralay Mukhopadhyay, Diane Opatt, Joseph A. Sparano

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Maintenance of clinical efficacy after dose reduction of ixabepilone plus capecitabine in patients with anthracycline- and taxane-resistant metastatic breast cancer: A retrospective analysis of pooled data from 2 phase III randomized clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences